Exhibition Information

  • 17th January 2024

Exhibition Opening Hours

  • Friday 24th May 15:00 – 18:00
  • Saturday 25th May 09:00 – 17:00
  • Sunday 26th May 09:00 – 12:00

Exhibiting Companies

AGEPHA Pharma is a leading multi-national, family-owned pharmaceutical company focused on bringing treatments to patients who need them most. Since 1947, we’ve invested in proven therapies, including a wide range of pharmaceuticals, medical devices, and pharmaceutical supplements, all backed by a highly qualified team of clinical scientists and regulatory experts. We are committed to addressing unmet needs through novel preparations or orphan drugs. For more than 70 years we have been working closely with the clinical community to understand unmet needs and find new ways to address them, all while keeping patients at the heart of all that we do. 

AJL Ophthalmic, S.A. is the only Spanish company (July 1992) dedicated to the r&D, manufacture and marketing of medical devices in the field of Ophthalmology.

The company has reached a leading market postion thanks to the fulfillment of very exigent Regulatory and Quality Control Requirements, 3000 m2 facilities with cutting-edge tecnology as well as the most qualified personnel for the manufacture of its products.

AJL has an extensive sales network with presence in more than 80 countries.

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases, and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com 

Dompé farmaceutici (www.dompe.com) is a private, rapidly scaling international biopharmaceutical company founded in Milan, Italy, with a 130-year legacy of medical innovation. The entire supply chain is managed – from initial drug discovery to final manufacturing and product commercialization. The R&D department is anchored by EXSCALATE, a structure-based virtual screening platform developed in-house that leverages one of the most powerful supercomputing and artificial intelligence platforms in the world. Today, Dompé employs more than 800 people worldwide and maintains a US commercial operations hub in the San Francisco Bay Area as well as an R&D presence in Boston.

Leading manufacturer of reusable and disposable high quality Ophthalmic Instruments with focus on the latest developments of corneal transplant procedures. 

Based in Como, “Made in Italy”, innovation, research and style at the service of premium quality. 




  1. Eye Bank DMEK guarded punch and Tzamalis DMEK punch for one-step graft preparation 
  1. Smart DMEK graft inserting solutions 






Espansione Group is an established player in the MedTech industry focusing on ophthalmic solutions to treat various conditions via patented, certified, light-based technologies such as Light Modulation® Low-level Light Therapy (LM® LLLT), it’s signature photobiomodulation (PMB) technology, and Optimal Power Energy® Intense Pulsed Light (OPE® IPL). Since 1981, Espansione Group has delivered the highest standard in the industry—pushed on by expert craftsmanship and family-owned values coupled with a global mindset and aspiration. Every day, the company invests heavily in researching and developing the Espansione Ecosystem of technologies and solutions to achieve its ambition: establishing new paradigms in ophthalmology and beyond, driven by its desire to provide its partners and their patients with the best, certified medical technologies. With more than 6 international patents and over 1,100 solutions installed worldwide, Espansione Group’s technologies are responsible for the betterment of thousands of people worldwide, with over 400,000 yearly treatments being carried out each year with its solutions.  

Heidelberg Engineering continuously optimizes imaging and healthcare IT technologies to provide ophthalmic diagnostic solutions that empower clinicians to improve patient care. From its inception in 1990, the company has collaborated with scientists, clinicians and industry to develop innovative products that deliver clinically relevant benefits.  

Uncompromising quality and education play a large part in fostering the diagnostic confidence that has become synonymous with the global brand.  

The growing product portfolio combines these core technologies: confocal microscopy, scanning lasers and optics, optical coherence tomography (OCT), real-time image processing and analytics, multimodal image management solutions (PACS), electronic medical records (EMR) and large-scale data analysis. 

Founded in 2003, Horus Pharma is an independent French pharmaceutical laboratory, specialising in ophthalmology which is part of the French & European landscape. 

Since the creation of the Laboratory, Horus Pharma has been a pioneer in the development of the preservative-free formulations and products and has extended its expertise into dermatology and cosmetics.  

The genesis of KÔL comes from the observation that there are still unmet needs for treatments in corneal pathologies when much research effort is devoted to retinal pathologies.  

Laboratoires KÔL was established in February 2020 to provide solutions to needs not yet covered in the field of ophthalmology.  

KÔL is thus a new generation of pharmaceutical laboratory:  

  • A French startup, at the heart of a dynamic entrepreneurial network in Clermont-Ferrand: one of the cradles of ophthalmology in France,   
  • A startup with an international ambition, proud and keen to export our French know-how. 


For the last 150 years, we have been pioneers in ophthalmology. By developing treatments, providing information and sharing knowledge with specialists around the world, we enable everyone to keep their eyes wide open. 

Lumibird Medical is a division of the Lumibird Group : the global leader in the development of solid-state lasers for scientific and industrial use. Its mission is to improve patient quality of life with innovative diagnostic and treatment solutions dedicated to healthcare professionals under the 3 brand names: Ellex, Quantel Medical and Optotek Medical. 

Lumibird Medical innovates and extends its operations worldwide to disseminate its expertise and better meet the expectations of healthcare professionals around the world. This global presence is supplemented by a network of distributors covering a total of 110 countries. 


Since 1895 OCULUS has been a trusted partner for eye care professionals around the world. With the highest attention to detail, our devices are designed and manufactured at the OCULUS headquarters in Germany. 

Stop by our tabletop space to find out why it is clever to integrate the Pentacam® to your practice.

Learn about the new software of our non-contact Tonometer Corvis® ST, get informed about the Keratograph 5M and talk to our product specialists – we are here for you! 


OPTO HELLAS is the World’s 1st Representation Platform for manufacturers in Ophthalmology field as: 
OPTO HELLAS infrastructure in the EMEA and LATAM markets supports our partners in Administration, Logistic, Branding, Marketing, Positioning, Sales and Service for our exclusive distributor network. 
As the fastest growing medical device supplier with activity in more than 78 countries with a distribution network of 54 collaborators in the region of EMEA and LATAM, we “Redefine Vision Together”‘ with our partners 

Our core business is to discover and commercialize innovative
products in eye care with proven clinical evidence to create new
Our focus lies on corneal cross-linking, the non-invasive correction of
ecstatic corneal disorders and the new method for the treatment of
infectious keratitis, bullous keratopathy and Fuch’s dystrophy. In
partnership with our distribution partners we provide physicians
around the world the possibility to maintain and improve eye health
care for their patients

SIFI is a leading international ophthalmic company, focusing on eye care since 1935. 

SIFI develops, manufactures, and markets innovative therapeutic solutions for patients with ophthalmic conditions, and is fully committed to providing ophthalmologists and their patients with a wide range of therapeutic solutions to treat ophthalmic disorders, including innovative pharmaceuticals, medical devices and food supplements. 

SIFI’s mission is to improve people’s lives through meaningful innovation in eye care. 

Moreover, SIFI is strongly committed to generate long-term sustainable value for customers, employees, shareholders, and society at large. 

SIFI concentrates its R&D and manufacturing in Italy exporting towards more than 20 countries, with a direct presence in Italy, Spain, France, Romania, Mexico and Turkey. 


URSAPHARM Arzneimittel GmbH is an internationally active, medium sized pharmaceutical company.  

Thanks to its broad and high-quality product range it has established itself as a market leader in Germany and as one of the leading providers in Europe in the field of “dry eye” treatment. 

Since its foundation in 1974, URSAPHARM has been known for its consistent transfer of innovative pharmaceutical concepts into successful drugs and medical devices. 

The company is headquartered in Saarbrücken, Germany, and has ten foreign subsidiaries. It has around 800 employees and has distribution partnerships in over 80 countries. 


Exhibition Bookings for Paris 2024 are Open

EuCornea invites you to participate at the 15th EuCornea Congress taking place in Paris, France.

The annual congress is expected to attract 500 Cornea and Ocular Surface Disease Specialists with buying power and influence over purchasing decisions.